All accepted abstracts are available in the Journal for ImmunoTherapy of Cancer (JITC).

Abstract Titles

Poster Presentation Dates

All odd numbered posters will be presented on Wednesday, Nov. 11, from 5:15-5:45 p.m. EST and Friday, Nov. 13, from 4:40-5:10 p.m. EST. Even numbered posters will be presented on Thursday, Nov. 12, from 4:50-5:20 p.m. EST and Saturday, Nov. 14, from 1-1:30 p.m. EST.

Posters will be on display from 8 a.m. on Monday, Nov. 9, until the virtual poster hall closes on December 31, 2020.

#	Type	Title	Authors	Category	Keywords
404	Poster Presentation	ALX148, a CD47 blocker, in combination with standard chemotherapy and antibody regimens in patients with gastric/gastroesophageal junction (GC) cancer and head and neck squamous cell carcinoma (HNSCC)	Keun-Wook Lee, MD, PhD; Hyun C. Chung, MD, PhD; Won Seog Kim, MD; Laura Q. Chow, MD; Nehal Lakhani, MD, PhD; Wells Messersmith, MD; Yung-Jue Bang, MD PhD; Patricia LoRusso, DO; Philip S. Fanning, PhD; Pierre Squifflet, MSc; Feng Jin, PhD; Alison Forgie, PhD; Hong I. Wan, PhD; Jaume Pons, PhD; Sophia S. Randolph, MD, PhD; Justin F. Gainor, MD;	In-Progress Clinical Trials	Antibody; Antigen presenting cells; Checkpoint blockade; Chemotherapy; Clinical trial; Costimulation; Monocyte/Macrophage; Myeloid cells; Solid tumors; Tumor microenvironment